Large-scale testing (Phase 3)Study completedNCT04936308
What this trial is testing
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 453